These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 24881749)
1. Neuroleptic malignant syndrome induced by combination therapy with tetrabenazine and tiapride in a Japanese patient with Huntington's disease at the terminal stage of recurrent breast cancer. Nozaki I; Furukawa Y; Kato-Motozaki Y; Ikeda T; Tagami A; Takahashi K; Ishida C; Komai K Intern Med; 2014; 53(11):1201-4. PubMed ID: 24881749 [TBL] [Abstract][Full Text] [Related]
2. Neuroleptic malignant syndrome related to tetrabenazine introduction and haloperidol discontinuation in Huntington's disease. Mateo D; Muñoz-Blanco JL; Giménez-Roldán S Clin Neuropharmacol; 1992 Feb; 15(1):63-8. PubMed ID: 1533561 [TBL] [Abstract][Full Text] [Related]
3. Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders. Guay DR Am J Geriatr Pharmacother; 2010 Aug; 8(4):331-73. PubMed ID: 20869622 [TBL] [Abstract][Full Text] [Related]
4. Tetrabenazine as a cause of neuroleptic malignant syndrome. Ossemann M; Sindic CJ; Laterre C Mov Disord; 1996 Jan; 11(1):95. PubMed ID: 8771075 [No Abstract] [Full Text] [Related]
5. Tetrabenazine in the treatment of hyperkinetic movement disorders. Kenney C; Jankovic J Expert Rev Neurother; 2006 Jan; 6(1):7-17. PubMed ID: 16466307 [TBL] [Abstract][Full Text] [Related]
6. Neuroleptically induced dystonia in Huntington's disease: a case report. Schott K; Ried S; Stevens I; Dichgans J Eur Neurol; 1989; 29(1):39-40. PubMed ID: 2523309 [TBL] [Abstract][Full Text] [Related]
7. Neuroleptic malignant syndrome with aripiprazole in Huntington's disease. Gahr M; Orth M; Abler B Mov Disord; 2010 Oct; 25(14):2475-6. PubMed ID: 20669301 [No Abstract] [Full Text] [Related]
8. Neuroleptic malignant syndrome caused by dopamine-depleting drugs in a patient with Huntington disease. Burke RE; Fahn S; Mayeux R; Weinberg H; Louis K; Willner JH Neurology; 1981 Aug; 31(8):1022-5. PubMed ID: 6115336 [TBL] [Abstract][Full Text] [Related]
9. Neuroleptic Malignant Syndrome Induced by Olanzapine in a Patient with Huntington's Disease. Moreno JL; Palau Fayos JM; Díaz de Santiago A; García de Yébenes J J Huntingtons Dis; 2012; 1(1):31-2. PubMed ID: 25063189 [No Abstract] [Full Text] [Related]
10. Deutetrabenazine (Austedo) for Huntington's chorea and tardive dyskinesia. Med Lett Drugs Ther; 2018 Apr; 60(1545):65-68. PubMed ID: 29667946 [No Abstract] [Full Text] [Related]
11. Review of deutetrabenazine: a novel treatment for chorea associated with Huntington's disease. Dean M; Sung VW Drug Des Devel Ther; 2018; 12():313-319. PubMed ID: 29497277 [TBL] [Abstract][Full Text] [Related]